Wang, Yaning

Model‐Informed Drug Development: Current US Regulatory Practice and Future Considerations

Wang, Y., Zhu, H., Madabushi, R., Liu, Q., Huang, S., & Zineh, I. (2019) · Clinical Pharmacology & Therapeutics

Pharmaceutical studies and practicesStatistical Methods in Clinical Trials

Cited by 228

The utility of modeling and simulation in drug development and regulatory review

Huang, S.-M., Abernethy, D. R., Wang, Y., Zhao, P., & Zineh, I. (2013) · Journal of Pharmaceutical Sciences

Statistical Methods in Clinical TrialsPharmaceutical studies and practices

Cited by 206

Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation

Kuemmel, C., Yang, Y., Zhang, X., Florian, J., Zhu, H., Tegenge, M., Huang, S., Wang, Y., Morrison, T., & Zineh, I. (2020) · CPT: Pharmacometrics & Systems Pharmacology

Pharmaceutical studies and practicesStatistical Methods in Clinical Trials

Cited by 177

The US Food and Drug Administration's Model‐Informed Drug Development Paired Meeting Pilot Program: Early Experience and Impact

Madabushi, R., Benjamin, J. M., Grewal, R., Pacanowski, M. A., Strauss, D. G., Wang, Y., Zhu, H., & Zineh, I. (2019) · Clinical Pharmacology & Therapeutics

Pharmaceutical studies and practicesPharmaceutical Economics and Policy

Cited by 39

Regulatory Review of Acetaminophen Clinical Pharmacology in Young Pediatric Patients

Ji, P., Wang, Y., Li, Z., Doddapaneni, S., Hertz, S., Furness, S., & Sahajwalla, C. G. (2012) · Journal of Pharmaceutical Sciences

Pharmaceutical studies and practicesPharmacogenetics and Drug Metabolism

Cited by 24